Overview
Meirong Zang practices practicing medicine in Shijiazhuang, China.
Zang is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Multiple Myeloma, Chromosome 12p Deletion, and Plasmacytoma.
They are actively involved in clinical research, co-authoring 17 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Meirong R. Zang
Is Meirong R. Zang a top-rated expert for Multiple Myeloma?
MediFind is an objective health platform that identifies experts based on real-world data. Meirong R. Zang is classified as an Advanced expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Meirong R. Zang participate in research or clinical trials?
Yes. Meirong R. Zang has published 17 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Meirong R. Zang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Multiple MyelomaZang isAdvanced. Learn about Multiple Myeloma.
- Experienced
- Chromosome 12p DeletionZang isExperienced. Learn about Chromosome 12p Deletion.
- PlasmacytomaZang isExperienced. Learn about Plasmacytoma.